Gilead Sciences Is on an FDA Approval Hot Streak. Should You Buy the Stock Like There's No Tomorrow?

Summary

A Motley Fool opinion piece discusses Gilead Sciences' recent streak of FDA approvals and whether investors should buy the stock. The provided text contains only the headline, with no specific drugs, dates, or data given.